Intellectual Capital in a <i>Q</i>‐Theory of Ag‐Biotech Mergers

Schimmelpfennig, David; King, John L.; Naseem, Anwar

doi:10.1111/j.0092-5853.2003.00542.x

Cited by 5 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two variables control for industry differences. Pharma is set to one if the acquirer is in the pharmaceutical/biotech industry, since past research has found unique characteristics of the acquisition process between pharmaceutical and biotechnology firms (Kalaitzandonakes, ; Schimmelpfennig, King, and Naseem, ; Schweizer, ). We also used Compustat to construct the four‐firm concentration ratio at the SIC three‐digit classification level.…”

Section: Methodsmentioning

confidence: 99%

Technological overlap, technological capabilities, and resource recombination in technological acquisitions

Sears

Hoetker

2013

Strategic Management Journal

218

216

View full text Add to dashboard Cite

The performance of technological acquisitions depends heavily on the overlap between the knowledge bases of the target and acquirer. We argue that overlap is best viewed as two distinct constructs: target overlap, the proportion of the target's knowledge base that the acquirer already possesses, and acquirer overlap, the proportion of the acquirer's knowledge base duplicated by the target. Each affects the value created from the firms' technological capabilities differently due to absorptive capacity, knowledge redundancy, and organizational disruption. Further, the low quantity of innovations observed in acquisitions with low target overlap may conceal an offsetting increase in their novelty. Copyright © 2013 John Wiley & Sons, Ltd.

show abstract

Section: Methodsmentioning

confidence: 99%

Technological overlap, technological capabilities, and resource recombination in technological acquisitions

Sears

Hoetker

2013

Strategic Management Journal

218

216

View full text Add to dashboard Cite

show abstract

“…Research input quantity is measured by deflated R&D expenditure, and research input price by the corresponding price deflator. Patent counts are, following standard practice, employed to represent knowledge output (Griliches 1990;Graff, Rausser, and Small 2003;Schimmelpfennig, King, and Naseem 2003), and knowledge output prices are measured by average patent values. Our data sample spans 1980-2003.…”

Section: Data and Institutional Backgroundmentioning

confidence: 99%

Public Investment and Industry Incentives in Life‐Science Research

Wang

Xia

Buccola³

2009

American J Agri Economics

View full text Add to dashboard Cite

Life-science research has shifted rapidly from the public to the private sector, raising questions about government's remaining role. We shed light on the issue by employing a dynamic investment-response model to examine the public's impact on industry life-science research effort and success. We find that government expenditures in both basic biological research and agricultural and medical science create substantial spillovers for private firms. The spillovers are, unfortunately, partly nullified by government competition for scarce research inputs. Yet even after accounting for such competition, public investment has been strongly complementary to private investment. Indeed, opportunities created through public research are the principal source of growth in industry life sciences.

show abstract

Patent Characteristics and Patent Ownership Change in Agricultural Biotechnology

Gjonça

Yiannaka²

2017

Innovation, Technology, and Knowledge Management

View full text Add to dashboard Cite

Intellectual Capital in a Q‐Theory of Ag‐Biotech Mergers

Cited by 5 publications

References 9 publications

Technological overlap, technological capabilities, and resource recombination in technological acquisitions

Technological overlap, technological capabilities, and resource recombination in technological acquisitions

Public Investment and Industry Incentives in Life‐Science Research

Patent Characteristics and Patent Ownership Change in Agricultural Biotechnology

Contact Info

Product

Resources

About